Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of Mucorales|
|Citation:||Antimicrobial Agents and Chemotherapy, 2015; 59(3):1745-1750|
|Publisher:||American Society for Microbiology|
|A. Espinel-Ingroff, A. Chakrabarti, A. Chowdhary, S. Cordoba, E. Dannaoui, P. Dufresne, A. Fothergill, M. Ghannoum, G. M. Gonzalez, J. Guarro, S. Kidd, C. Lass-Flörl, J. F. Meis, T. Pelaez, A. M. Tortorano and J. Turnidge|
|Abstract:||Clinical breakpoints (CBPs) have not been established for the Mucorales and any antifungal agent. In lieu of CBPs, epidemiologic cutoff values (ECVs) are proposed for amphotericin B, posaconazole, and itraconazole and four Mucorales species. Wild-type (WT) MIC distributions (organisms in a species-drug combination with no detectable acquired resistance mechanisms) were defined with available pooled CLSI MICs from 14 laboratories (Argentina, Australia, Canada, Europe, India, Mexico, and the United States) as follows: 10 Apophysomyces variabilis, 32 Cunninghamella bertholletiae, 136 Lichtheimia corymbifera, 10 Mucor indicus, 123 M. circinelloides, 19 M. ramosissimus, 349 Rhizopus arrhizus, 146 R. microsporus, 33 Rhizomucor pusillus, and 36 Syncephalastrum racemosum isolates. CLSI broth microdilution MICs were aggregated for the analyses. ECVs comprising ≥95% and ≥97.5% of the modeled populations were as follows: amphotericin B ECVs for L. corymbifera were 1 and 2 μg/ml, those for M. circinelloides were 1 and 2 μg/ml, those for R. arrhizus were 2 and 4 μg/ml, and those for R. microsporus were 2 and 2 μg/ml, respectively; posaconazole ECVs for L. corymbifera were 1 and 2, those for M. circinelloides were 4 and 4, those for R. arrhizus were 1 and 2, and those for R. microsporus were 1 and 2, respectively; both itraconazole ECVs for R. arrhizus were 2 μg/ml. ECVs may aid in detecting emerging resistance or isolates with reduced susceptibility (non-WT MICs) to the agents evaluated.|
|Keywords:||Humans; Mucorales; Mucormycosis; Amphotericin B; Triazoles; Itraconazole; Antifungal Agents; Microbial Sensitivity Tests; Drug Resistance, Multiple, Fungal|
|Rights:||© 2015 by the American Society for Microbiology.|
|Appears in Collections:||Microbiology and Immunology publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.